• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

减少脑栓塞:使用新型脑栓塞保护装置的体外研究。

Reduction of Cerebral Emboli: In vitro Study with a Novel Cerebral Embolic Protection Device.

作者信息

Haiman Guy, Nazif Tamim, Moses Jeffrey W, Ashkenazi Amit, Margolis Pauliina, Lansky Alexandra J

机构信息

Keystone Heart Ltd., Caesarea, Israel.

Department of Cardiology, Columbia University Medical Center, New York, NY, USA.

出版信息

Med Devices (Auckl). 2020 Mar 12;13:67-73. doi: 10.2147/MDER.S234961. eCollection 2020.

DOI:10.2147/MDER.S234961
PMID:32210643
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7075333/
Abstract

AIM

To assess the efficacy of the TriGUARD , a novel cerebral embolic protection (CEP) device in reducing cerebral embolization by deflecting embolic debris away from the cerebral circulation using a quantitative in vitro model.

METHODS AND RESULTS

This in vitro study assessed the ability of a cerebral embolic protection device to deflect embolic debris, by measuring the percent of particles and air bubbles, 200 µm and 300 µm in size, from entering the cerebral circulation compared to unprotected controls. A 3D printed silicone model of the ascending aorta, the aortic arch with its three major cerebral arteries and the descending aorta was connected to a custom-made simulator that mimics physiological pulsatile flow patterns of the left ventricle. Comparative analyses were used to assess the efficacy of the cerebral embolic protection device to deflect particles and air bubbles away from the major cerebral arteries. The percent of particles and air bubbles entering the major cerebral arteries was significantly lower with cerebral embolic protection compared to unprotected controls (p<0.0001). Cerebral protection resulted in 97.4-100% reduction in air bubble counts, and 97.4-97.8% reduction in particle counts compared to unprotected controls.

CONCLUSION

This in vitro study used simulated physiologic flow conditions in an aortic arch model to demonstrate >97% efficacy of the TriGUARD CEP device, in reducing cerebral embolization of particulate and air bubbles of 200 µm to 300 µm in size.

摘要

目的

使用定量体外模型评估新型脑栓塞保护(CEP)装置TriGUARD通过使栓塞碎片偏离脑循环来减少脑栓塞的疗效。

方法与结果

这项体外研究通过测量与未受保护的对照组相比,尺寸为200微米和300微米的颗粒和气泡进入脑循环的百分比,评估了一种脑栓塞保护装置使栓塞碎片偏离的能力。一个3D打印的升主动脉、带有三条主要脑动脉的主动脉弓和降主动脉的硅胶模型连接到一个定制模拟器上,该模拟器模拟左心室的生理搏动血流模式。采用比较分析来评估脑栓塞保护装置使颗粒和气泡偏离主要脑动脉的疗效。与未受保护的对照组相比,使用脑栓塞保护时进入主要脑动脉的颗粒和气泡百分比显著降低(p<0.0001)。与未受保护的对照组相比,脑保护使气泡计数减少了97.4-100%,颗粒计数减少了97.4-97.8%。

结论

这项体外研究在主动脉弓模型中使用模拟生理流动条件,证明TriGUARD CEP装置在减少尺寸为200微米至300微米的颗粒和气泡的脑栓塞方面具有>97%的疗效。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d875/7075333/83fdf1766d7e/MDER-13-67-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d875/7075333/9fcde00eee95/MDER-13-67-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d875/7075333/83fdf1766d7e/MDER-13-67-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d875/7075333/9fcde00eee95/MDER-13-67-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d875/7075333/83fdf1766d7e/MDER-13-67-g0002.jpg

相似文献

1
Reduction of Cerebral Emboli: In vitro Study with a Novel Cerebral Embolic Protection Device.减少脑栓塞:使用新型脑栓塞保护装置的体外研究。
Med Devices (Auckl). 2020 Mar 12;13:67-73. doi: 10.2147/MDER.S234961. eCollection 2020.
2
A percutaneous aortic device for cerebral embolic protection during cardiovascular intervention.经皮主动脉装置,用于心血管介入期间的脑栓塞保护。
J Vasc Surg. 2011 Jul;54(1):174-181.e1. doi: 10.1016/j.jvs.2010.11.109. Epub 2011 Jan 14.
3
TriGuard HDH embolic deflection device for cerebral protection during transcatheter aortic valve replacement.用于经导管主动脉瓣置换术中脑保护的TriGuard HDH栓子偏转装置。
Catheter Cardiovasc Interv. 2017 Feb 15;89(3):470-477. doi: 10.1002/ccd.26566. Epub 2016 Apr 28.
4
Safety and performance of a novel embolic deflection device in patients undergoing transcatheter aortic valve replacement: results from the DEFLECT I study.新型栓塞转向装置在经导管主动脉瓣置换术中的安全性和性能:来自 DEFLECT I 研究的结果。
EuroIntervention. 2015 May;11(1):75-84. doi: 10.4244/EIJY15M04_01.
5
First-in-man experience with a new embolic deflection device in transcatheter aortic valve interventions.经导管主动脉瓣介入治疗中新型栓塞转向装置的首例人体应用经验。
EuroIntervention. 2012 May 15;8(1):51-6. doi: 10.4244/EIJV8I1A9.
6
The TriGuard embolic deflection device for prevention of stroke and cerebral embolization during transcatheter aortic valve replacement.用于经导管主动脉瓣置换术中预防中风和脑栓塞的TriGuard栓子偏转装置。
Expert Rev Med Devices. 2015;12(6):649-51. doi: 10.1586/17434440.2015.1086642. Epub 2015 Sep 12.
7
Exploring the Difference in Post-procedural Stroke Rates Between Patients with Aortic Stenosis Who Undergo Transcatheter Aortic Valve Replacement Versus Surgical Aortic Valve Replacement.探索接受经导管主动脉瓣置换术与外科主动脉瓣置换术的主动脉瓣狭窄患者术后中风发生率的差异。
Cureus. 2018 Apr 17;10(4):e2494. doi: 10.7759/cureus.2494.
8
Embolic protection in patients undergoing transaortic transcatheter aortic valve replacement: initial experience with the TriGuard HDH embolic deflection device.经主动脉经导管主动脉瓣置换术患者的栓塞保护:TriGuard HDH栓塞偏转装置的初步经验。
J Card Surg. 2016 Oct;31(10):617-622. doi: 10.1111/jocs.12822. Epub 2016 Aug 30.
9
Significant Differences in Debris Captured by the Sentinel Dual-Filter Cerebral Embolic Protection During Transcatheter Aortic Valve Replacement Among Different Valve Types.不同类型经导管主动脉瓣置换术中 Sentinel 双滤网脑保护装置捕获的碎屑存在显著差异。
JACC Cardiovasc Interv. 2018 Sep 10;11(17):1683-1693. doi: 10.1016/j.jcin.2018.06.018. Epub 2018 Aug 25.
10
Complete filter-based cerebral embolic protection with transcatheter aortic valve replacement.经导管主动脉瓣置换术中基于滤器的全脑栓塞保护
Catheter Cardiovasc Interv. 2018 Mar 1;91(4):790-797. doi: 10.1002/ccd.27323. Epub 2017 Sep 12.

本文引用的文献

1
Rate of peri-procedural stroke observed with cerebral embolic protection during transcatheter aortic valve replacement: a patient-level propensity-matched analysis.经导管主动脉瓣置换术中使用脑保护装置时观察到的围手术期卒中发生率:一项基于患者倾向评分匹配的分析。
Eur Heart J. 2019 May 1;40(17):1334-1340. doi: 10.1093/eurheartj/ehy847.
2
Topographical distribution of perioperative cerebral infarction associated with transcatheter aortic valve implantation.经导管主动脉瓣植入术相关围手术期脑梗死的部位分布。
Am Heart J. 2018 Mar;197:113-123. doi: 10.1016/j.ahj.2017.12.008. Epub 2017 Dec 8.
3
Neurologic Complications of Unprotected Transcatheter Aortic Valve Implantation (from the Neuro-TAVI Trial).
无保护经导管主动脉瓣植入术的神经系统并发症(来自Neuro-TAVI试验)
Am J Cardiol. 2016 Nov 15;118(10):1519-1526. doi: 10.1016/j.amjcard.2016.08.013. Epub 2016 Aug 23.
4
Effect of a Cerebral Protection Device on Brain Lesions Following Transcatheter Aortic Valve Implantation in Patients With Severe Aortic Stenosis: The CLEAN-TAVI Randomized Clinical Trial.经导管主动脉瓣植入术治疗重度主动脉瓣狭窄患者中脑保护装置对脑损伤的影响:CLEAN-TAVI 随机临床试验。
JAMA. 2016 Aug 9;316(6):592-601. doi: 10.1001/jama.2016.10302.
5
Filter-based cerebral embolic protection with transcatheter aortic valve implantation: the randomised MISTRAL-C trial.基于滤器的经导管主动脉瓣植入术脑保护:随机 MISTRAL-C 试验。
EuroIntervention. 2016 Jul 20;12(4):499-507. doi: 10.4244/EIJV12I4A84.
6
A prospective randomized evaluation of the TriGuard™ HDH embolic DEFLECTion device during transcatheter aortic valve implantation: results from the DEFLECT III trial.经导管主动脉瓣植入术中TriGuard™ HDH栓塞偏折装置的前瞻性随机评估:DEFLECT III试验结果
Eur Heart J. 2015 Aug 14;36(31):2070-2078. doi: 10.1093/eurheartj/ehv191. Epub 2015 May 19.
7
Incidence and predictors of debris embolizing to the brain during transcatheter aortic valve implantation.经导管主动脉瓣植入术中碎块栓塞至脑部的发生率及预测因素。
JACC Cardiovasc Interv. 2015 Apr 27;8(5):718-24. doi: 10.1016/j.jcin.2015.01.020.
8
Safety and performance of a novel embolic deflection device in patients undergoing transcatheter aortic valve replacement: results from the DEFLECT I study.新型栓塞转向装置在经导管主动脉瓣置换术中的安全性和性能:来自 DEFLECT I 研究的结果。
EuroIntervention. 2015 May;11(1):75-84. doi: 10.4244/EIJY15M04_01.
9
Stroke: an infrequent but devastating complication in cardiovascular interventions.中风:心血管介入治疗中一种罕见但具有毁灭性的并发症。
Circulation. 2012 Dec 18;126(25):2921-4. doi: 10.1161/CIRCULATIONAHA.112.149492.
10
First-in-man use of a novel embolic protection device for patients undergoing transcatheter aortic valve implantation.首例新型栓塞保护装置在经导管主动脉瓣植入术中的应用。
EuroIntervention. 2012 May 15;8(1):43-50. doi: 10.4244/EIJV8I1A8.